PREVIOUS
✖
Pfizer India
December 11 , 2020
1369 days
838
0
- Pfizer India has become the first pharma company to approach the Drugs Controller General of India (DGCI) to seek an emergency use authorization of its vaccine for COVID-19 in India.
- Already UK and Bahrain have given their permission for Pfizer’s vaccine BNT162b2.
- This vaccine requires the extremely low temperature for storing at minus 70 degrees Celsius.
- The Serum Institute of India (SII) seeks emergency use authorization for the Oxford - Astra Zeneca vaccine COVID-19 vaccine candidate 'Covishield'.
- The Serum Institute of India (SII) is the World's largest vaccine manufacturer.
Leave a Reply
Your Comment is awaiting moderation.